Although SUMF1 and SUMF2 expression have similar patterns in BLCA tumors, SUMF2 lacks the enzymatic activity necessary for the production of FGly due to the absence of two catalytic cysteines (Cys336 and Cys341) compared with the SUMF1 active site [17]. This evidence concerns the gene SUMF2 and bladder transitional cell carcinoma.